Atlas Trials

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Clinical trial NCT05455424 · COMPLETED

Trial details

NCT number
NCT05455424
Sponsor
University Hospital Southampton NHS Foundation Trust
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Mesothelioma, Malignant
Start date
2022-07-11
Primary completion
2025-01-31
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.